The increasing amount of patients with obesity and type 2 diabetes benefit greatly from the recently developed GIPR:GLP-1R co-agonists. These novel compounds lead to substantial weight loss, offering a revolutionary approach to patients worldwide. Although the hormone glucose-dependent insulinotropic polypeptide (GIP) was already shown by Helmholtz Munich scientists to decrease body weight via the brain GIP receptor, the ...
Duesseldorf/Kuopio (ots) - - Partners join forces to improve lives of millions of Parkinson’s patients worldwide with a transformative technology-based solution - Gerresheimer participates in seed-round of the Finnish MedTech company and university spin-off - Monitoring and personalized medication adjustment in ...
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36143/ Images for journalists: https://mediatum.ub.tum.de/1553341 NEWS RELEASE Neuronal circuits in the brain 'sense' our inner state Making balanced decisions ...
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35707/ High resolution images: https://mediatum.ub.tum.de/1520278 NEWS RELEASE The secret of motivation How neural circuits drive hungry individuals to peak ...
